New depression pill shows promise in Mid-Stage trial
NCT ID NCT07226661
First seen Nov 10, 2025 · Last updated May 09, 2026 · Updated 29 times
Summary
This study tests a new drug called SPN-821 in 230 adults with major depressive disorder who are already taking an antidepressant but still have symptoms. Participants will receive either SPN-821 or a placebo for about a month to see if the drug safely improves depression more than placebo. The main goal is to measure changes in depression scores using a standard rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Collaborative Neuroscience Network
RECRUITINGGarden Grove, California, 92845, United States
Conditions
Explore the condition pages connected to this study.